首页 > 市场调查报告书 > 医疗设备

体外诊断

市场调查报告书

商品编码

1441277

全球纸本诊断市场规模、份额、成长分析（按产品类型、设备类型）- 产业预测，2023-2030 年

Global Paper Diagnostics Market Size, Share, Growth Analysis, By Product(Lateral Flow Assays, Dipsticks), By Device Type(Diagnostic Devices, Monitoring Devices) - Industry Forecast 2023-2030

出版日期: 2024年02月18日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球纸本诊断市场规模预估为83.5亿美元，从2023年的90.2亿美元成长到2031年的166亿美元，预测期间（2024-2031年）复合年增长率为8%，预计还将增长至 9000 万美元。

作为可携式且经济高效的照护现场检测选择，纸本诊断市场正在经历显着成长。这些设备在纸本基材上进行医学测试，可以快速且准确地进行诊断，这在偏远和资源有限的地区尤其有益。由于易于使用、设备要求最低以及检测疟疾、爱滋病毒和糖尿病等疾病的有效性等优势，该市场正在不断增长。纸本诊断具有生产成本低、易于处置、无需专业人员的优点。应用包括环境监测、食品安全检测和临床诊断。对即时、分散医疗服务的需求正在增加，特别是在服务不足的地区，这正在推动纸本诊断的普及。随着技术的进步，微流体、与感测器的整合以及与智慧型手机的兼容性增加了这种潜力。然而，挑战仍然存在，例如确保结果的稳健性和准确性、在不同条件下保持稳定性以及扩大可检测分析物的范围。透过持续的研究、製造流程的改进以及医疗保健提供者、学术机构和行业相关人员之间不断加强的合作，纸本诊断市场预计将继续保持上升趋势。纸本解决方案为实现世界经济实惠且快速诊断的目标提供了一条充满希望的道路。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东/非洲
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2021年）
主要市场参与者所采取的策略
关键成功策略
近期市集活动
主要企业市场占有率（2021年）

主要企业简介

Becton, Dickinson and Company（BD）
Siemens Healthineers
bioMerieux
Mologic Ltd.
Diagnostics For All
Micronics
Alere Inc.（Now part of Abbott）
EKF Diagnostics
Nova Biomedical
Zoetis Inc.
Abaxis（Part of Zoetis）
Cytodiagnostics Inc.
Bio-Rad Laboratories, Inc.
ACON Laboratories, Inc.
CellFree Sciences Co., Ltd.

简介目录

Product Code: SQMIG35H2179

Global Paper Diagnostics Market size was valued at USD 8.35 Billion in 2022 and is poised to grow from USD 9.02 Billion in 2023 to USD Billion 16.69 by 2031, at a CAGR of 8% during the forecast period (2024-2031).

The paper diagnostics market has seen remarkable growth as a portable and cost-effective option for point-of-care testing. These devices conduct medical tests on paper-based substrates, offering swift and precise diagnoses, particularly beneficial in remote or resource-limited areas. The market is expanding due to its advantages, such as ease of use, minimal equipment requirements, and effectiveness in detecting diseases like malaria, HIV, and diabetes. Paper diagnostics offer benefits such as low manufacturing costs, easy disposal, and reduced need for specialized personnel. They find applications in environmental monitoring, food safety testing, and clinical diagnostics. The increasing demand for immediate, decentralized healthcare, especially in underserved regions, has propelled the popularity of paper diagnostics. As technology progresses, integration with microfluidics, sensors, and compatibility with smartphones enhance their potential. Challenges persist, including ensuring the robustness and accuracy of results, maintaining stability under diverse conditions, and broadening the scope of detectable analytes. Through ongoing research, improved manufacturing processes, and growing collaborations between healthcare providers, academic institutions, and industry players, the paper diagnostics market is anticipated to continue its upward trajectory. Paper-based solutions offer a promising avenue to meet the global goal of affordable and rapid diagnostic accessibility.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Paper Diagnostics and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.

Global Paper Diagnostics Market Segmental Analysis

The Paper Diagnostics Market is segmented by product, device type, application, end-use, and region. Based on product the market is segmented as lateral flow assays, dipsticks, and paper based microfluidics. Based on device type the market is segmented as, diagnostic devices, monitoring devices. Based on application the market is segmented as, clinical diagnostics, cancer, infectious diseases, liver disorders, other, food quality testing, and environmental monitoring. Based on end-use the market is segmented as, home healthcare, assisted living healthcare facilities, hospital and clinics, and others. Regional the market is segmented as, North America, Asia Pacific, Latin America, and Middle East & Africa (MEA).

Drivers of the Global Paper Diagnostics Market

Paper diagnostics facilitate quick and cost-effective point-of-care testing, enabling swift diagnosis and treatment, particularly in resource-limited or rural areas where standard laboratory facilities are lacking.

Paper-based devices are an attractive option due to their relatively low manufacturing costs, which is especially beneficial in regions with limited healthcare budgets or high patient volumes.

Restraints in the Global Paper Diagnostics Market

The entrenched use of traditional diagnostic methods within healthcare systems poses challenges for paper diagnostics to complement or substitute them in certain scenarios.

There may be a need to educate and gain acceptance from healthcare professionals and patients before widespread adoption of paper diagnostics, particularly in regions where these technologies are less familiar.

Market Trends of the Global Paper Diagnostics Market

Emergence of Point-of-Care Testing: The adoption of point-of-care testing was spurred by the demand for fast and convenient diagnostic solutions. The shift towards decentralized healthcare aligned with the ability of paper diagnostics to provide rapid results without specialized equipment.

Technological Progress: The functionalities of paper-based devices were enhanced through the integration of microfluidics, smartphone connectivity, and biosensors. These advancements enabled more sophisticated assays, improved accuracy, and enhanced data transfer.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Paper Diagnostics Market by Product

Market Overview
Lateral Flow Assays
Dipsticks
and Paper Based Microfluidics

Global Paper Diagnostics Market by Device Type

Market Overview
Diagnostic Devices
Monitoring Devices

Global Paper Diagnostics Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Becton, Dickinson and Company (BD)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioMerieux
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mologic Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Diagnostics For All
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Micronics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alere Inc. (Now part of Abbott)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EKF Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nova Biomedical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zoetis Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abaxis (Part of Zoetis)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cytodiagnostics Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ACON Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CellFree Sciences Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments